Key statistics
On Thursday, Renovaro Inc (2Q5:BER) closed at 0.477, 30.33% above the 52 week low of 0.366 set on Oct 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4755 |
---|---|
High | 0.5070 |
Low | 0.4715 |
Bid | 0.4375 |
Offer | 0.517 |
Previous close | 0.4795 |
Average volume | 0.00 |
---|---|
Shares outstanding | 158.72m |
Free float | 77.25m |
P/E (TTM) | -- |
Market cap | 79.96m USD |
EPS (TTM) | -0.9343 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 20:52 GMT.
More ▼
Announcements
- Renovaro Issues Shareholder Letter and Provides Corporate Update
- RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
- Renovaro Announces Strategic Restructuring and Leadership Transition
- PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
- Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
- RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
- RenovaroCube Announces Strategic Offering of Up to 20% Ownership
- Renovaro, Inc. Announces $10 million in Equity Committed
- Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
- Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
More ▼